Cargando…
T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructural changes relevant to early stages of pathol...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350145/ https://www.ncbi.nlm.nih.gov/pubmed/34116150 http://dx.doi.org/10.1016/j.neuroimage.2021.118214 |
_version_ | 1783735691321016320 |
---|---|
author | Wearn, Alfie R. Nurdal, Volkan Saunders-Jennings, Esther Knight, Michael J. Madan, Christopher R. Fallon, Sean-James Isotalus, Hanna K. Kauppinen, Risto A. Coulthard, Elizabeth J. |
author_facet | Wearn, Alfie R. Nurdal, Volkan Saunders-Jennings, Esther Knight, Michael J. Madan, Christopher R. Fallon, Sean-James Isotalus, Hanna K. Kauppinen, Risto A. Coulthard, Elizabeth J. |
author_sort | Wearn, Alfie R. |
collection | PubMed |
description | A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructural changes relevant to early stages of pathology. Recent evidence suggests heterogeneity of T2 may be a more informative MRI measure of early pathology than absolute T2. Here we test whether T2 markers of brain integrity precede the volume changes we know are present in established AD and whether such changes are most marked in medial temporal lobe (MTL) subfields known to be most affected early in AD. We show that T2 heterogeneity was greater in people with mild cognitive impairment (MCI; n = 49) compared to healthy older controls (n = 99) in all MTL subfields, but this increase was greatest in MTL cortices, and smallest in dentate gyrus. This reflects the spatio-temporal progression of neurodegeneration in AD. T2 heterogeneity in CA1-3 and entorhinal cortex and volume of entorhinal cortex showed some ability to predict cognitive decline, where absolute T2 could not, however further studies are required to verify this result. Increases in T2 heterogeneity in MTL cortices may reflect localised pathological change and may present as one of the earliest detectible brain changes prior to atrophy. Finally, we describe a mechanism by which memory, as measured by accuracy and reaction time on a paired associate learning task, deteriorates with age. Age-related memory deficits were explained in part by lower subfield volumes, which in turn were directly associated with greater T2 heterogeneity. We propose that tissue with high T2 heterogeneity represents extant tissue at risk of permanent damage but with the potential for therapeutic rescue. This has implications for early detection of neurodegenerative diseases and the study of brain-behaviour relationships. |
format | Online Article Text |
id | pubmed-8350145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Academic Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83501452021-09-01 T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment Wearn, Alfie R. Nurdal, Volkan Saunders-Jennings, Esther Knight, Michael J. Madan, Christopher R. Fallon, Sean-James Isotalus, Hanna K. Kauppinen, Risto A. Coulthard, Elizabeth J. Neuroimage Article A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructural changes relevant to early stages of pathology. Recent evidence suggests heterogeneity of T2 may be a more informative MRI measure of early pathology than absolute T2. Here we test whether T2 markers of brain integrity precede the volume changes we know are present in established AD and whether such changes are most marked in medial temporal lobe (MTL) subfields known to be most affected early in AD. We show that T2 heterogeneity was greater in people with mild cognitive impairment (MCI; n = 49) compared to healthy older controls (n = 99) in all MTL subfields, but this increase was greatest in MTL cortices, and smallest in dentate gyrus. This reflects the spatio-temporal progression of neurodegeneration in AD. T2 heterogeneity in CA1-3 and entorhinal cortex and volume of entorhinal cortex showed some ability to predict cognitive decline, where absolute T2 could not, however further studies are required to verify this result. Increases in T2 heterogeneity in MTL cortices may reflect localised pathological change and may present as one of the earliest detectible brain changes prior to atrophy. Finally, we describe a mechanism by which memory, as measured by accuracy and reaction time on a paired associate learning task, deteriorates with age. Age-related memory deficits were explained in part by lower subfield volumes, which in turn were directly associated with greater T2 heterogeneity. We propose that tissue with high T2 heterogeneity represents extant tissue at risk of permanent damage but with the potential for therapeutic rescue. This has implications for early detection of neurodegenerative diseases and the study of brain-behaviour relationships. Academic Press 2021-09 /pmc/articles/PMC8350145/ /pubmed/34116150 http://dx.doi.org/10.1016/j.neuroimage.2021.118214 Text en © 2021 The Author(s). Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wearn, Alfie R. Nurdal, Volkan Saunders-Jennings, Esther Knight, Michael J. Madan, Christopher R. Fallon, Sean-James Isotalus, Hanna K. Kauppinen, Risto A. Coulthard, Elizabeth J. T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment |
title | T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment |
title_full | T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment |
title_fullStr | T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment |
title_full_unstemmed | T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment |
title_short | T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment |
title_sort | t2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350145/ https://www.ncbi.nlm.nih.gov/pubmed/34116150 http://dx.doi.org/10.1016/j.neuroimage.2021.118214 |
work_keys_str_mv | AT wearnalfier t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT nurdalvolkan t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT saundersjenningsesther t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT knightmichaelj t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT madanchristopherr t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT fallonseanjames t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT isotalushannak t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT kauppinenristoa t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment AT coulthardelizabethj t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment |